Jazz Pharmaceuticals (JAZZ) Stock Trades Up, Here Is Why [Yahoo! Finance]
Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ)
Last jazz pharmaceuticals plc - ordinary shares earnings: 2/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
jazzpharma.com
Company Research
Source: Yahoo! Finance
For the quarter, Jazz posted revenue of $1.2 billion, representing a 10.1% increase year-over-year and beating analyst estimates. The company's adjusted earnings of $6.64 per share also surpassed expectations. However, this positive performance was contrasted with the company's full-year revenue guidance, which fell short of consensus estimates. Despite the mixed outlook, investors appeared to focus on the strong quarterly results and a significant improvement in profitability. The company's operating margin expanded to 21.2%, up from 17.5% in the same period last year, indicating greater operational efficiency. Is now the time to buy Jazz Pharmaceuticals? Access our full analysis report here, it's free What Is The Market Telling Us Jazz Pharmaceuticals's shares are somewhat volatile and have had 12 moves greater than 5% over the last year. But moves this big are rare even for Jazz Pharmaceuticals and indicate this news significantly impacted the market's perception of the busi
Show less
Read more
Impact Snapshot
Event Time:
JAZZ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JAZZ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JAZZ alerts
High impacting Jazz Pharmaceuticals plc - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
JAZZ
News
- A Look At Jazz Pharmaceuticals (JAZZ) Valuation After Record Quarter And 2026 Guidance [Yahoo! Finance]Yahoo! Finance
- Jazz Pharmaceuticals plc Q4 2025 Earnings Call Summary [Yahoo! Finance]Yahoo! Finance
- Jazz Pharmaceuticals (JAZZ) had its price target raised by Royal Bank Of Canada from $191.00 to $195.00. They now have an "outperform" rating on the stock.MarketBeat
- Jazz Pharmaceuticals (JAZZ) had its price target raised by Morgan Stanley from $225.00 to $226.00. They now have an "overweight" rating on the stock.MarketBeat
- Jazz Pharmaceuticals (JAZZ) had its price target raised by Wells Fargo & Company from $235.00 to $250.00. They now have an "overweight" rating on the stock.MarketBeat
JAZZ
Earnings
- 2/24/26 - Beat
JAZZ
Sec Filings
- 2/24/26 - Form 10-K
- 2/24/26 - Form 8-K
- 1/21/26 - Form 4
- JAZZ's page on the SEC website